Related Experiment Video
Updated: Sep 11, 2025

Desthiobiotin-Streptavidin-Affinity Mediated Purification of RNA-Interacting Proteins in Mesothelioma Cells
Published on: April 25, 2018
YBX1: an RNA/DNA-binding protein that affects disease progression.
Xifeng Zheng1,2, Feng Zeng2, Yan Lei3
1Department of Radiation Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine Central South University/Hunan Cancer Hospital, Changsha, Hunan, China.
Y-box protein 1 (YBX1) is a key factor in cancer progression and development. This review details YBX1's roles in various biological processes and its potential as a therapeutic target.
Area of Science:
- Molecular Biology
- Oncology
- Developmental Biology
Background:
- Y-box protein 1 (YBX1) is a multifunctional RNA/DNA-binding protein with a conserved cold shock domain (CSD).
- YBX1 plays critical roles in transcription, translation, and DNA damage repair, and is found in both cytoplasm and nucleus.
- Elevated YBX1 levels correlate with malignant tumor progression and poor prognosis, identifying it as a cancer therapy target.
Purpose of the Study:
- To comprehensively review the multifaceted roles of YBX1 in biological processes.
- To elucidate the mechanisms underlying YBX1's involvement in tumor progression.
- To explore YBX1's impact on embryonic development, tissue differentiation, and its relationship with disease outcomes.
Main Methods:
- Literature review of studies on YBX1 function.
- Analysis of YBX1's role in various cellular processes.
- Investigation of upstream regulatory factors influencing YBX1.
Main Results:
- YBX1 is implicated in tumor progression, embryonic development, bone differentiation, cartilage formation, and adipogenesis.
- Upstream regulatory factors significantly impact YBX1's biological functions.
- YBX1 expression levels are closely linked to disease prognosis and treatment efficacy.
Conclusions:
- YBX1 is a critical regulator with diverse functions in normal development and disease.
- Understanding YBX1's regulatory network is essential for developing targeted cancer therapies.
- YBX1 represents a promising biomarker for disease prognosis and a potential therapeutic target.
More Related Videos
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
06:41In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
Related Concept Videos
Pleiotropy
Epigenetic Regulation
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Canonical Wnt Signaling Pathway
The Y Chromosome Determines Maleness
Evolution
Around 300 million years ago, the two sex chromosomes diverged from two identical autosomal chromosomes. Over time, the Y chromosome has lost most of its genes, shrinking in size....
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...